ALAN ANDERSON: Open Payments
NPI 1124175146 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,317 in 31 payments from 9 companies in 2025. Trend: 2023 $27,877 · 2024 $24,479 · 2025 $24,317
Consulting: $21,175Travel & lodging: $2,503Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $15,585 |
| Agios Pharmaceuticals, Inc. | 13 | $8,519 |
| CSL Behring | 2 | $54 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $43 |
| Adaptive Biotechnologies Corporation | 1 | $34 |
| Novo Nordisk Inc | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| RARE DISEASE THERAPEUTICS, INC. | 1 | $19 |
| Y-mAbs Therapeutics, Inc. | 1 | $17 |
Products named: PYRUKYND, HYMPAVZI, HEMGENIX, HEMANGEOL, clonoSEQ, Alhemo, Xromi, DANYELZA.
Industry payments across SC — which companies pay providers there.
